Summary
Overview
Work History
Education
Skills
Websites
Accomplishments
Timeline
Generic

ANIS TRIKI

Thought Leader Liaison | KOL Strategy & Scientific Impact
Etoy

Summary

Results-driven Medical Affairs and Commercial leader with over a decade of experience cultivating strategic partnerships with Key Opinion Leaders (KOLs) within the oncology and specialty care sectors. Blending scientific expertise with business acumen, excels in market development, account management, and medical engagement to harmonize cutting-edge science with corporate goals. Demonstrated success in KOL mapping, insights generation, cross-functional leadership, and flawless execution of peer-to-peer initiatives that drive tangible growth and enhance patient outcomes.

Overview

11
11
years of professional experience
4
4
Languages

Work History

Medical Science Liaison – Urogenital Tumors

Johnson & Johnson Innovative Medicine
Zug
01.2024 - Current
  • Built and maintained a network of 80+ top-tier KOLs in uro-oncology across Switzerland, increasing engagement and shaping scientific leadership in the field.
  • Delivered 40+ high-impact scientific discussions and educational programs per year, driving adoption of innovative therapies and ensuring alignment with the latest clinical evidence.
  • Collected and synthesized 200+ actionable field insights annually, directly influencing strategic planning, identifying unmet needs, and supporting new study proposals.
  • Represented J&J at10+ national and international medical congresses per year, strengthening expert relationships and enhancing company visibility in uro-oncology.
  • Partnered cross-functionally with medical, marketing, and commercial teams to align field initiatives with brand strategy, contributing to double-digit growth in therapy uptake.

Product & Account Specialist – Uro-Oncology

Johnson & Johnson Innovative Medicine
Geneva
01.2022 - 12.2023
  • Executed KOL engagement strategies with 50+ national and regional experts, coordinating advisory boards and 20+ speaker programs annually fully aligned with brand goals.
  • Drove 15–20% year-over-year growth in therapy adoption by tailoring scientific education initiatives to clinicians’ unmet needs and latest evidence.
  • Awarded “Best Performance EMEA” (Top 1%) for exceptional results in KOL engagement, medical education, and market development across Switzerland.

Key Account Manager – Oncology, Pain, Pulmonology, Diabetes

Mundipharma
Lausannne
01.2018 - 01.2021
  • Planned and executed KOL engagement strategies with 20+ national and regional experts, organizing 5–7 commercial events and 10+ peer-to-peer speaker programs per year, fully aligned with brand and medical objectives.
  • Achieved 15–20% growth in therapy uptake year-over-year by delivering targeted scientific education initiatives addressing specific clinical practice gaps.



Medical Sales Representative – Gynecology

Effik
Lausanne
01.2017 - 01.2019
  • Established and nurtured strategic relationships with 40+ gynecologists, delivering 3+ tailored scientific programs annually to address clinical needs.
  • Expanded market presence by increasing expert engagement and targeted education initiatives, resulting in double-digit growth in product awareness and adoption

Medical Science Liaison – Genetic Diagnostics

Gene Predictis
Lausanne
01.2015 - 01.2016
  • Established and nurtured strategic partnerships with 30+ leading gynecologists across Switzerland, acting as a trusted scientific advisor and ensuring continuous engagement through regular scientific exchanges.
  • Designed and delivered 10+ customized scientific programs and workshops per year, addressing evidence-based medicine, clinical practice challenges, and emerging therapeutic options.
  • Expanded market presence and influence by strengthening expert engagement and targeted educational initiatives, contributing to double-digit growth in product awareness and adoption, as well as positioning the company as a reference partner in the women’s health segment.

Education

MBA -

ESSEC Business School
Paris
04.2025 - 11 2026

DAS - Management of Clinical Trials

Université De Genève
Geneva University
01.2021 - 1 2022

Specialist Diploma - Pharmaceutical Industry

SHQA Academy
Bern University
08.2018

Bachelor of Science - Molecular Biology & Genetics

Université Joseph Fourier
Grenoble
01.1999 - 1 2002

Skills

  • KOL Engagement & Influence

  • Strategic Planning & Brand Alignment

  • Advisory Boards & Speaker Programs

  • Cross-Functional Collaboration

  • Scientific & Medical Education

  • Market Insights & Competitive Intelligence

  • Compliance Excellence (PhRMA / HCC)

  • Market Development & Account Management

  • Program Management & Event Execution

Accomplishments

  • Best Performance Award – EMEA for exceptional KOL engagement and market development.
  • Executed 30+ scientific events, advisory boards, and peer-to-peer programs with measurable impact.
  • Built a trusted network of KOLs and experts in oncology/urology, influencing therapeutic decision-making.
  • Translated complex clinical science into actionable insights to shape strategies and improve patient outcomes.

Timeline

MBA -

ESSEC Business School
04.2025 - 11 2026

Medical Science Liaison – Urogenital Tumors

Johnson & Johnson Innovative Medicine
01.2024 - Current

Product & Account Specialist – Uro-Oncology

Johnson & Johnson Innovative Medicine
01.2022 - 12.2023

DAS - Management of Clinical Trials

Université De Genève
01.2021 - 1 2022

Key Account Manager – Oncology, Pain, Pulmonology, Diabetes

Mundipharma
01.2018 - 01.2021

Medical Sales Representative – Gynecology

Effik
01.2017 - 01.2019

Medical Science Liaison – Genetic Diagnostics

Gene Predictis
01.2015 - 01.2016

Bachelor of Science - Molecular Biology & Genetics

Université Joseph Fourier
01.1999 - 1 2002

Specialist Diploma - Pharmaceutical Industry

SHQA Academy
ANIS TRIKIThought Leader Liaison | KOL Strategy & Scientific Impact